Integration of ABO phenotype or high-risk genotypes with established thrombophilia markers could improve risk prediction and inform future research on personalized anticoagulation strategies [25,46,47,56,57,58]. The gene discussed is ABO; the disease is Rare hereditary thrombophilia.